The British Life Sciences Web Portal
This is a free web portal for the life sciences in the UK and Ireland... » read more
- MVM Life Sciences Acquires 7.5% Stake in Valneva SE (2016-12-01)
> Funds managed by MVM Life Science Partners LLP (“MVM”) to invest a total of €15.2 million in a simultaneous private placement of 2.9 million newly issued shares and purchase of a further tranche of existing shares > Issue price of €2.60 per share corresponds t...
- Orchard Tx: Strategic Alliance with Oxford BioMedica (2016-11-29)
Orchard Therapeutics (“Orchard”), a biotechnology company dedicated to bringing transformative ex-vivo gene therapies to patients with serious and life-threatening orphan diseases announces today that it has entered into a strategic alliance with Oxford BioMedica p...
- Themis Bioscience Closes €10m Series B Financing Round (2016-11-29)
The vaccine development specialist Themis Bioscience successfully closed a Series B financing round of 10 Mio Euro. The fresh capital will be used to complete a phase 2 clinical trial of its lead product, a vaccine candidate against Chikungunya fever. Further produ...
- GSK Submits MAA for Shingles Vaccine Shingrix to EMA (2016-11-25)
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the regulatory submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval for its candidate shingles vaccine, ShingrixTM, for the prevention of herpes zoster ...
- GHO Capital Closes €660m Private Equity Healthcare Fund (2016-11-25)
GHO Capital, the European specialist investor in healthcare, today announces the successful final close for GHO Capital Fund I LP, a €660 million private equity fund which has been raised to seize the highly attractive and underpenetrated investment opportunity in ...
- Kymab Secures $100m Series C Funding, Led by ORI Fund (2016-11-24)
New investors ORI Healthcare Fund L.P. with participation by Shenzhen Hepalink Pharmaceutical Co., Ltd., join follow-on investments from existing shareholders Kymab Group Limited ("Kymab"), a leading monoclonal antibody biopharmaceutical group, announced today...
- GSK Starts Phase 3 with Daprodustat for Anaemia in CKD (2016-11-24)
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a phase III development programme investigating daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a treatment for anaemia associated with chronic kidney disease ...
- LIFNano Therapeutics Receives £1m Funding by Innovate UK (2016-11-24)
Cambridgeshire based impact venture LIFNano have been awarded £1m funding by Innovate UK in the Biomedical Catalyst competition, 2016. LIFNanoRx promises a new generation of treatments for currently untreatable diseases using simple and clean technology. T...
- Ablynx Announces Results for First Nine Months of 2016 (2016-11-23)
Strong clinical progress across our product portfolio Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced its financial results, summarising the non-audited financial position for the first nine months of 2016, a business update for the year-to-date a...
- GSK: Phase 3 Study with Mepolizumab Meets Endpoints in EGPA (2016-11-23)
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that both co-primary endpoints and all secondary endpoints were met in a pivotal phase III study investigating the efficacy and safety of mepolizumab, an IL-5 antagonist, in patients with relapsing and refractory ...
Life-Sciences-UK.com is your doorway to the British and Irish life sciences!
[LSUK] provides free, up-to-date and structured access to
in the UK and Ireland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!Start here with the latest News!
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)